450
Participants
Start Date
January 27, 2020
Primary Completion Date
September 30, 2021
Study Completion Date
September 30, 2021
Tenofovir Alafenamide 25 MG for arm (A)
Tenofovir Alafenamide (TAF) will be provided, 25 mg Per Oral daily.
Tenofovir Disoproxil Fumarate 300mg for arm (B)
Tenofovir Disoproxil Fumarate (TDF) will be provided, 300 mg Per Oral daily.
RECRUITING
Shanghai Public Health Clinical Center, Fudan University, Zhujing
RECRUITING
Pingdingshan Hospital of Chongqing Public Health Medical Treatment Center, Shapingba
RECRUITING
First Affiliated Hospital of Fujian Medical University, Fuzhou
RECRUITING
The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen
RECRUITING
Hainan General Hospital, Haikou
RECRUITING
The Third Hospital of Qinhuangdao, Qinhuangdao
RECRUITING
The Fourth Hospital of Harbin Medical University, Harbin
RECRUITING
Xiangya Hospital, Central South University, Changsha
RECRUITING
Ganzhou Fifth People's Hospital, Ganzhou
RECRUITING
Shengjing Hospital of China Medical University, Shenyang
RECRUITING
Yuyao People's Hospital of Zhejiang Province, Yuyao
Lead Sponsor
New Discovery LLC
INDUSTRY